GDPR Considerations for DtP Supply Chains
Regulatory, Supply Chain
One of the primary challenges with Direct-to-Patient (DtP) supply chains is maintaining patient privacy. This is further complicated by the GDPR (General Data Protection Regulation), which is broadly designed to protect the right to personal data privacy for all EU citizens. The GCSG DTP Sub-team provides an overview of the key GDPR considerations and recommendations for organizations engaged in DtP.
Related Education Resources.
All Resources2019 European Knowledge Forum: Presentation and Workshop Slides
Topics: Communication, Conference, Personal Development, Pharma Industry
Presentation
Members
EMA Guidance on Trial Mgmt during COVID-19
Topics: Health Care, Pharma Industry, Strategic Planning
Guidance Document
Free
The Use of Direct-to-Patient Methods in Decentralized Clinical Trials in Israel
Topic: Direct-to-Patient
White Paper
Free
